Target intelligence / Profile preview

TINAG antisense RNA 1 (TINAG-AS1)

Target
TINAG-AS1
Molecular classification
Long non-coding RNA, Antisense RNA, Non-coding RNA
01

Overview

TINAG antisense RNA 1 (TINAG-AS1) is a long non-coding RNA (lncRNA) classified as an antisense transcript because it is transcribed from the DNA strand opposite to a protein-coding gene, specifically overlapping or corresponding to the TINAG gene[1]. Antisense RNAs, especially in the long non-coding class, are recognized as regulators of gene expression, often through interaction with the transcript (mRNA) of their associated sense gene, thereby influencing its processing, stability, splicing, or translation[4][6][7]. The specific function of TINAG-AS1 has not been extensively characterized in published literature or major gene databases as of now, and there are no known disease associations, therapeutic roles, or drug interactions[1]. Like other long non-coding antisense RNAs, TINAG-AS1 may play a role in the regulation of its sense gene (TINAG) or participate in broader gene regulation mechanisms, but this has not been experimentally established for TINAG-AS1 in particular.

02

Mechanism of action

Not applicable; TINAG-AS1 itself is not a drug target or direct effector molecule

03

Biological functions

Regulation of gene expression
04

Disease associations

No direct disease associations reported for TINAG-AS1 itself; by analogy with similar antisense RNAs, potential but unproven roles in gene regulation relevant to disease

Beyond the preview

Go deeper on TINAG antisense RNA 1 (TINAG-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TINAG antisense RNA 1 (TINAG-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call